GFRα-1 mRNA in dopaminergic and nondopaminergic neurons in the substantia nigra and ventral tegmental area

Journal of Comparative Neurology

Volumn 441, Issue 2, 2001, Pages 106-117

  Sarabi, Arezou ^a   Hoffer, Barry J ^a   Olson, Lars ^b   Morales, Marisela ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Calcium binding proteins; GDNF; Glutamic acid decarboxylase; Interneurons; Parkinson's disease; aminobutyric acid

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; CALBINDIN; CALCIUM BINDING PROTEIN; CALRETININ; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR FAMILY RECEPTOR ALPHA 1; GLUTAMATE DECARBOXYLASE; MESSENGER RNA; OXIDOPAMINE; PARVALBUMIN; RECEPTOR; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG; CALCIUM BINDING PROTEINS; DOPAMINE; ONCOPROTEIN; PROTEIN TYROSINE KINASE; PROTO ONCOGENE PROTEINS; PROTO ONCOGENE PROTEINS RET; PROTO-ONCOGENE PROTEINS RET; RECEPTOR PROTEIN TYROSINE KINASES;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CELL LEVEL; CELL SUBPOPULATION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIMBIC CORTEX; MALE; MESENCEPHALON; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SUBSTANTIA NIGRA; THALAMUS; VENTRAL TEGMENTUM; ANIMAL; CYTOLOGY; GENETICS; METABOLISM; NERVE CELL; RAT STRAIN;

ANIMAL; CALCIUM-BINDING PROTEINS; DOPAMINE; GAMMA-AMINOBUTYRIC ACID; MALE; NEURONS; PROTO-ONCOGENE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR PROTEIN-TYROSINE KINASES; RNA, MESSENGER; SUBSTANTIA NIGRA; SUPPORT, U.S. GOV'T, P.H.S.; TYROSINE 3-MONOOXYGENASE; VENTRAL TEGMENTAL AREA;

EID: 0035841910     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/cne.1400     Document Type: Article

References (56)

1. GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo
2. Calcium-binding proteins in the nervous system
3. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain
4. Efferent connections of the substantia nigra and ventral tegmental area in the rat
5. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations
6. Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons
7. GDNF is an age-specific survival factor for sensory and autonomic neurons
8. Evidence for a GABAergic inhibitory nigrotectal pathway in the rat
9. Dopaminergic neurons protected from degeneration by GDNF gene therapy
10. Neurturin shares receptors and signal transduction pathways with glial cell line-derived neurotrophic factor in sympathetic neurons
11. GDNF signaling through the Ret receptor tyrosine kinase
12. Morphological and functional effects of intranigrally administered GDNF in normal rhesus monkeys
13. The neostriatal mosaic: Compartmental distribution of calcium-binding proteins and parvalbumin in the basal ganglia of the rat and monkey
14. The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems
15. Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: Sparing of calbindin-D28k-containing cells
16. Substantia nigra pars reticulata neurons in Parkinson's disease
17. GDNF: A potent survival factor for motoneurons present in peripheral nerve and muscle
18. Cell clusters in the nucleus accumbens of the rat, and the mosaic relationship of opiate receptors, acetylcholinesterase and subcortical afferent termination
19. Biochemistry of Parkinson's disease with special reference to the dopaminergic systems
20. Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo
21. Parvalbumin and calbindin D-28k in the entopeduncular nucleus, subthalamic nucleus, and substantia nigra of the rat as revealed by double-immunohistochemical methods
22. Biochemical pathophysiology of Parkinson's disease
23. Calbindin-D28k-containing neurons in animal models of neurodegeneration: Possible protection from excitotoxicty
24. GDNF-induced activation of the rat protein tyrosine kinase is mediated by GDNFR-α a novel receptor for GDNF
25. Sensitive non-radioisotopic in situ hybridization histochemistry: Demonstration of tyrosine hydroxylase gene expression in the rat brain and adrenal
26. Cerebral cortical calbindin D28k and parvalbumin neurons in Down's syndrome
27. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease
28. Dopaminergic neurons expressing calbindin in normal and parkinsonian monkeys
29. Rescue of adult mouse motoneurons from injury-induced cell death by glial cell line-derived neurotrophic factor
30. Midbrain dopaminergic neurons in the mouse: Co-localization with calbindin-D28k and calretinin
31. GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons
32. Cytoarchitectural distribution of calcium binding proteins in midbrain dopaminergic regions of rats and humans
33. GDNF increases the density of cells containing calbindin but not of cells containing calretinin in culture rat and human fetal nigraI tissue
34. The 5-HT3 receptor is present in different subpopulation of GABAergic neurons in the rat telencephalon
35. Does the calcium binding protein cairetinin protect dopaminergic neurons against degeneration in Parkinson's disease?
36. Glial cell line-derived neurotrophic factor promotes the survival and morphologic differentiation of purkinje cells
37. Calretinin and calbindin-D28k in dopaminergic neurons of the rat midbrain: A triple-labeling immunohistochemical study
38. Cellular and patterns of expression of Ret and glial cell line-derived neurotrophic factor receptor alpha mRNAs
39. Calcium-binding proteins in primate basal ganglia
40. Inhibition of phosphatidylinostitol 3-kinase activity blocks cellular differentiation mediated by giial cell line-derived neurotrophic in dopaminergic neurons
41. GDNF triggers a novel retindependent src kinase family-coupled signaling via a GPI-linked GDNF receptor alpha 1
42. Effect of GDNF on fetal septal forebrain transplant in ocula
43. Calretinin and calbindin-D28k in rat brain: Patterns of partial co-localization
44. Low dopamine transporter mRNA levels in midbrain regions containing calbindin
45. GFRα-1 is expressed in parvalbumin GABAergic neurons in the hippocampus
46. Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo
47. The projections of the ventral tegmental area and adjacent regions: A combined fluorescent retrograde tracer and immunofluorescence study in the rat
48. Characterization of a multicomponent receptor for GDNF
49. Functional receptor for GDNF encoded by the c-ret proto-oncogene
50. Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-ret proto-oncogene, and GDNF receptor-α indicates multiple mechanisms of trophic action in the adult rat CNS
51. Ret-dependent and independent mechanisms of glial cell line-derived neurotrophic factor signaling in neuronal cells
52. Glial cell line-derived neurotrophic factor induces Ret-mediated lamellipodia formation
53. Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's disease
54. The pattern of innervation of the corpus striatum by the substantia nigra
55. Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28k